Company LungLife AI, Inc. Deutsche Boerse AG
Equities
9H4
USU5500L1045
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.162 EUR | +0.62% | +0.62% | -77.81% |
Apr. 05 | Transcript : LungLife AI, Inc., 2023 Earnings Call, Apr 05, 2024 | |
Apr. 04 | LungLife reports narrowed losses in year of "considerable achievement" | AN |
Business Summary
Number of employees: 15
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Royalty
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +89.93% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +89.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 40 | - |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
Chief Tech/Sci/R&D Officer | - | - | |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Sara Barrington
BRD | Director/Board Member | 57 | 18-12-31 |
Rebecca Reed
LAW | General Counsel | - | - |
Lara Baden
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gordon Davis
CHM | Chairman | 67 | 21-07-07 |
Andrew Boteler
BRD | Director/Board Member | 58 | 21-07-07 |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
James McCullough
BRD | Director/Board Member | 56 | 18-12-31 |
Sara Barrington
BRD | Director/Board Member | 57 | 18-12-31 |
Paul Pagano
CEO | Chief Executive Officer | 40 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,658,603 | 15,817,963 ( 51.59 %) | 0 | 51.59 % |
Company contact information
LungLife AI, Inc.
2545 West Hillcrest Drive Suite 140
91320, Thousand Oaks
+805 409 9868
http://www.lunglifeai.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.33% | 8.55B | |
+14.86% | 3.8B | |
+7.38% | 2.44B | |
-25.96% | 1.87B | |
-17.30% | 1.74B | |
+36.49% | 1.19B | |
+32.58% | 830M | |
-7.64% | 711M | |
-18.37% | 589M |
- Stock Market
- Equities
- LLAI Stock
- 9H4 Stock
- Company LungLife AI, Inc.